Dr. Martin-Immanuel Bittner is the CEO of Arctoris, the world's first fully automated drug discovery platform that he co-founded in Oxford in 2016. His goal is to change the way we approach drug discovery - moving towards a truly data-driven model, with the right data at the right time empowering us to make the right decisions, accelerating the path towards the clinic. He partners with biotech and pharma companies globally, delivering integrated drug discovery projects from idea to IND, enabled by a team of expert scientists and their unique technology platform.
How does turning the way we receive care inside out actually improve care and decrease costs? What are some of the strategies we can...
Is there a specific path to entrepreneurship MDs need to follow? What does the demand and supply dynamics in the nursing market look like?...
Join us as Lincoln Nadauld, CEO of Culmination Bio, delves into the crucial role of genomics-powered precision medicine in Oncology research. Discover the main...